Page last updated: 2024-12-06

guanoclor

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

guanoclor: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71835
CHEMBL ID2110641
CHEBI ID135992
SCHEMBL ID309602
SCHEMBL ID10904040
MeSH IDM0059301

Synonyms (48)

Synonym
compound 1029
nsc-108163
551-48-4
vatensol
guanoclor sulfate(usan)
1-[2-(2,6-dichlorophenoxy)ethylamino]guanidine
nsc92354
guanoclor
CHEBI:135992
2-[2-(2,6-dichlorophenoxy)ethylamino]guanidine
[[2-(2,6-dichlorophenoxy)ethyl]amino]guanidine
guanocloro [inn-spanish]
unii-m4hbt852yo
2-(2,6-dichlorophenoxy)ethylaminoguanidine
m4hbt852yo ,
guanoclor [inn:ban]
guanochlor
guanoclorum [inn-latin]
einecs 225-667-7
guanocloro
guanoclorum
5001-32-1
guanoclor [inn]
guanochlor [mi]
((2-(2,6-dichlorophenoxy)ethyl)amino)guanidine (2:1)
hydrazinecarboximidamide, 2-(2-(2,6-dichlorophenoxy)ethyl)-,(2:1)
guanoclor [who-dd]
SCHEMBL309602
2-[2-(2,6-dichlorophenoxy)ethyl]hydrazinecarboximidamide
guanoclorsulfat
CHEMBL2110641
hydrazinecarboximidamide, 2-[2-(2,6-dichlorophenoxy)ethyl]-
2-[2-(2,6-dichlorophenoxy)ethyl]hydrazinecarboximidamide #
XIHXRRMCNSMUET-UHFFFAOYSA-N
SCHEMBL10904040
guanochlorine
AC-30944
DTXSID10198184
n-{[2-(2,6-dichlorophenoxy)ethyl]amino}guanidine
AS-70067
AKOS027550031
BCP18875
Q5613775
DB13779
EX-A2920
2-(2-(2,6-dichlorophenoxy)ethyl)hydrazine-1-carboximidamide
HY-100796
2-(2-(2,6-dichlorophenoxy)ethyl)hydrazinecarboximidamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]